What is the functional role of the thalidomide binding protein cereblon?
- PMID: 22003441
- PMCID: PMC3193296
What is the functional role of the thalidomide binding protein cereblon?
Abstract
It has been found that nonsense mutation R419X of cereblon (CRBN) is associated with autosomal recessive non-syndromic mental retardation. Further experiments showed that CRBN binds to the cytosolic C-terminus of large-conductance Ca(++) activated potassium channel (BK(Ca)) α-subunit and the cytosolic C-terminus of a voltage-gated chloride channel-2 (ClC-2), suggesting that CRBN may play a role in memory and learning via regulating the assembly and surface expression of BK(Ca) and ClC-2 channels. In addition, it has also been found that CRBN directly interacts with the α1 subunit of AMP-activated protein kinase (AMPK) and prevents formation of a functional holoenzyme with regulatory subunits β and γ. Since AMPK is a master sensor of energy balance that inhibits ATP-consuming anabolic pathways and increases ATP-producing catabolic pathways, binding of CRBN with α1 subunit of AMPK may play a role in these pathways by regulating the function of AMPK. Furthermore, CRBN interacts with damaged DNA binding protein 1 and forms an E3 ubiquitin ligase complex with Cullin 4 where it functions as a substrate receptor in which the proteins recognized by CRBN might be ubiquitinated and degraded by proteasomes. Proteasome-mediated degradation of unneeded or damaged proteins plays a very important role in maintaining regular function of a cell, such as cell survival, dividing, proliferation and growth. Intriguingly, a new role for CRBN has been identified, i.e, the binding of immunomodulatory drugs (IMiDs), e.g. thalidomide, to CRBN has now been associated with teratogenicity and also the cytotoxicity of IMiDs, including lenalidomide, which are widely used to treat multiple myeloma patients. CRBN likely plays an important role in binding, ubiquitination and degradation of factors involved in maintaining function of myeloma cells. These new findings regarding the role of CRBN in IMiD action will stimulate intense investigation of CRBN's downstream factors involved in maintaining regular function of a cell.
Keywords: AMPK; BKCa; CRBN; ClC-2; Cul4A; DDB1; E3 ubiquitin ligase.
Similar articles
-
Regulation of AMPK Activity by CRBN Is Independent of the Thalidomide-CRL4CRBN Protein Degradation Axis.Pharmaceuticals (Basel). 2021 May 26;14(6):512. doi: 10.3390/ph14060512. Pharmaceuticals (Basel). 2021. PMID: 34073624 Free PMC article.
-
Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon.J Biol Chem. 2018 Apr 20;293(16):6187-6200. doi: 10.1074/jbc.M117.816868. Epub 2018 Feb 15. J Biol Chem. 2018. PMID: 29449372 Free PMC article.
-
A novel effect of thalidomide and its analogs: suppression of cereblon ubiquitination enhances ubiquitin ligase function.FASEB J. 2015 Dec;29(12):4829-39. doi: 10.1096/fj.15-274050. Epub 2015 Jul 31. FASEB J. 2015. PMID: 26231201 Free PMC article.
-
Cereblon in health and disease.Pflugers Arch. 2016 Aug;468(8):1299-309. doi: 10.1007/s00424-016-1854-1. Epub 2016 Jun 24. Pflugers Arch. 2016. PMID: 27343012 Review.
-
[Molecular Mechanism of CRBN in the Activity of Lenalidomid eagainst Myeloma--Review].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Aug;26(4):1240-1243. doi: 10.7534/j.issn.1009-2137.2018.04.050. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018. PMID: 30111438 Review. Chinese.
Cited by
-
A HAND to TBX5 Explains the Link Between Thalidomide and Cardiac Diseases.Sci Rep. 2017 May 3;7(1):1416. doi: 10.1038/s41598-017-01641-3. Sci Rep. 2017. PMID: 28469241 Free PMC article.
-
Mouse Monoclonal Antibodies Generated from Full Length Human Cereblon: Detection of Cereblon Protein in Patients with Multiple Myeloma.Int J Mol Sci. 2017 Sep 17;18(9):1999. doi: 10.3390/ijms18091999. Int J Mol Sci. 2017. PMID: 28926977 Free PMC article.
-
Lenalidomide Stabilizes the Erythropoietin Receptor by Inhibiting the E3 Ubiquitin Ligase RNF41.Cancer Res. 2016 Jun 15;76(12):3531-40. doi: 10.1158/0008-5472.CAN-15-1756. Epub 2016 Apr 6. Cancer Res. 2016. PMID: 27197154 Free PMC article.
-
Expression of the cereblon binding protein argonaute 2 plays an important role for multiple myeloma cell growth and survival.BMC Cancer. 2016 May 3;16:297. doi: 10.1186/s12885-016-2331-0. BMC Cancer. 2016. PMID: 27142104 Free PMC article.
-
Serum Cereblon (CRBN) Levels Predict Long Term Post- Lenalidomide-Dexamethasone Survival in Multiple Myeloma (MM) Patients and Correlate with Disease Characteristics.Int J Mol Sci. 2025 Jun 30;26(13):6341. doi: 10.3390/ijms26136341. Int J Mol Sci. 2025. PMID: 40650115 Free PMC article.
References
-
- Higgins JJ, Rosen DR, Loveless JM, Clyman JC, Grau MJ. A gene for nonsyndromic mental retardation maps to chromosome 3p25-pter. Neurology. 2000;55:335–340. - PubMed
-
- Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H. Identification of a primary target of thalidomide teratogenicity. Science. 327:1345–1350. - PubMed
-
- Dijkhuizen T, van Essen T, van der Vlies P, Verheij JB, Sikkema-Raddatz B, van der Veen AY, Gerssen-Schoorl KB, Buys CH, Kok K. FISH and array-CGH analysis of a complex chromosome 3 aberration suggests that loss of CNTN4 and CRBN contributes to mental retardation in 3pter deletions. Am J Med Genet A. 2006;140:2482–2487. - PubMed
-
- Xin W, Xiaohua N, Peilin C, Xin C, Yaqiong S, Qihan W. Primary function analysis of human mental retardation related gene CRBN. Mol Biol Rep. 2008;35:251–256. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials